Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype

After more than one year since the COVID-19 outbreak, patients with severe disease still constitute the bottleneck of the pandemic management. Aberrant inflammatory responses, ranging from cytokine storm to immune-suppression, were described in COVID-19 and no treatment was demonstrated to change th...

Descripción completa

Detalles Bibliográficos
Autores principales: Trombetta, Amelia C., Farias, Guilherme B., Gomes, André M. C., Godinho-Santos, Ana, Rosmaninho, Pedro, Conceição, Carolina M., Laia, Joel, Santos, Diana F., Almeida, Afonso R. M., Mota, Catarina, Gomes, Andreia, Serrano, Marta, Veldhoen, Marc, Sousa, Ana E., Fernandes, Susana M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265310/
https://www.ncbi.nlm.nih.gov/pubmed/34248984
http://dx.doi.org/10.3389/fimmu.2021.691725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265310/
https://www.ncbi.nlm.nih.gov/pubmed/34248984
http://dx.doi.org/10.3389/fimmu.2021.691725

Ejemplares similares